IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells

Cancer Research - United States
doi 10.1158/0008-5472.can-14-3016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen-Specific CD8+ T Cells Induced by Melanoma Vaccines

Cancer Research
Cancer ResearchOncology
2013English

Presence of Suppressor HIV-Specific CD8+ T Cells Is Associated With Increased PD-1 Expression on Effector CD8+ T Cells

Journal of Immunology
AllergyImmunology
2008English

PD-L1 Expression in Basaloid Squamous Cell Lung Carcinoma: Relationship to PD-1+ and CD8+ Tumor-Infiltrating T Cells and Outcome

Modern Pathology
Forensic MedicinePathology
2016English

Improved Survival of CAR‐T and Tumor‐specific T Cells Caused by Anti‐PD‐1 scFv‐producing CAR‐T Cells

Cancer Science
Cancer ResearchMedicineOncology
2019English

Virus-Specific CD8+ T Cells Infiltrate Melanoma Lesions and Retain Function Despite High PD-1 Expression

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-Tumor Activity

Cell Reports
BiochemistryGeneticsMolecular Biology
2019English

Modulating Immunometabolism of Tumor Specific CD8 T Cells to Enhance T Cell Based Therapy for Cancer

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Vaccination-Induced Functional Competence of Circulating Human Tumor-Specific CD8 T-Cells

International Journal of Cancer
Cancer ResearchOncology
2011English

Semaphorin 3A Induces Cytoskeletal Paralysis in Tumor-Specific CD8+ T Cells

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy